Nanobiotix Financials - Benzinga

Nanobiotix SA

NBTXNASDAQ

Trade with Public

Trade with Public

$33.46

가까이에: Sep 24, 5:00 PM EST

$32.75

-0.71-2.12%

프리마켓: 3:00 AM EST

실적: H1 2026 실적이 목 9월 24th에 시장 마감 후 발표되었습니다.

개요 뉴스 실적 전망 이벤트 목표가재무심리 비교 주식 보고서

Nanobiotix Financials

Nanobiotix (NBTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Nanobiotix H1 EPS $(0.82) Down From $(0.12) YoY, Sales $6.533M Down From $30.202M YoY

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.82) per share. This is a 583.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported $6.533 million in sales

Benzinga Newsdesk

PRO
UPDATE: Nanobiotix FY EPS $(0.58) Up From $(1.56) YoY, Sales $37.943M Miss $165.540M Estimate

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 62.82 percent increase over losses of $(1.56) per share from the same period last year. The company reported quarterly sales of $37.943

Benzinga Newsdesk

PRO
Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 137.18 percent decrease over earnings of $1.56 per share from the same period last year. The company reported quarterly sales of $37.943

Benzinga Newsdesk

Earnings Scheduled For March 31, 2026

Benzinga Insights

PRO
Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30

Benzinga Newsdesk

PRO
Nanobiotix H1 EPS $(0.12) Up From $(0.50) YoY, Sales $30.202M Up From $10.001M YoY

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.12) per share. This is a 76 percent increase over losses of $(0.50) per share from the same period last year. The company reported $30.202 million in sales this

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved